Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial
Title: | Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial |
---|---|
Authors: | Andrew R. Pettitt, Richard Jackson, Silvia Cicconi, Fotis Polydoros, Christina Yap, James Dodd, Matthew Bickerstaff, Michael Stackpoole, Umair T. Khan, Stacey Carruthers, Melanie Oates, Ke Lin, Sarah E. Coupland, Geetha Menon, Nagesh Kalakonda, Helen McCarthy, Adrian Bloor, Anna Schuh, Andrew Duncombe, Claire Dearden, Christopher Fegan, Ben Kennedy, Renata Walewska, Scott Marshall, Christopher P. Fox, Peter Hillmen |
Source: | Haematologica, Vol 105, Iss 12 (2020) |
Publisher Information: | Ferrata Storti Foundation, 2020. |
Publication Year: | 2020 |
Collection: | LCC:Diseases of the blood and blood-forming organs |
Subject Terms: | Diseases of the blood and blood-forming organs, RC633-647.5 |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 0390-6078 1592-8721 |
Relation: | https://haematologica.org/article/view/9646; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721 |
DOI: | 10.3324/haematol.2019.230805 |
Access URL: | https://doaj.org/article/53bc7354a2964c36992d8813be0e32a7 |
Accession Number: | edsdoj.53bc7354a2964c36992d8813be0e32a7 |
Database: | Directory of Open Access Journals |
ISSN: | 03906078 15928721 |
---|---|
DOI: | 10.3324/haematol.2019.230805 |
Published in: | Haematologica |
Language: | English |